Peter has spent more than 30 years working and advising in the biopharma services industry, including Elan Pharma, ICON, UDG Healthcare, Aptuit and Abzena.

Peter first became familiar with the Teckro founders Gary, Nigel and Jacek during his tenure as CEO of ICON. The founding trio sold their company to ICON, with Peter championing the acquisition of their clinical trial software. When the founders started Teckro, Peter enthusiastically supported the mission they set out and became Teckro chairman in 2015.

Peter is also chairman of Abzena and is a board member of Jazz Pharmaceuticals.

Peter Gray